016-8008765
KPJ Johor Specialist Hospital (JSH)
It was great to speak to a group of Great Eastern insurance agents from Negeri Sembilan about how hypertension and diabetes can affect our heart.
Venue changed to auditorium IJN as there were 80 pax! Full house!
Protect your heart, start from today!
I had a truly amazing experience at TCTAP 2023 in Seoul! I was delighted to share my knowledge by presenting two cases of IVL, with one generously provided by David Yong. Additionally, I had the privilege of presenting a case that involved a complication, which resulted in an excellent save. Overall, it was an enriching and memorable event.
Kick off Day 1 TCTAP with my 1st presentation of an IVL case, don with Datuk Dr Kumara.
Proud to represent IJN & ICSM to share a case of complication with great save at TCTAP Day 2.
Session was chaired by Dato Dr Amin, panelists were Datuk Dr Kumara, Dr Jaya etc
IJN team came to support ICSM session!
IJN team dinner at Seoul!
Last day of TCTAP, helped colleague Dr David Yong to present his IVL case, chaired by Prof Dr Chen Shao Liang, the father of DK-Crush from China! Great experience and glad to be able to learn from sifu!
Lastly, congratulate my colleague for getting the best presenter! With Dr Liew Hong Bang, HOD of Cardiology Department, Hospital Queen Elizabeth II, Sabah, Malaysia!
It was a great pleasure to be able to work with the CTO sinsei Dr Shinya Okazaki from Japan.
It was a 2 days CTO workshop organized by Medtronic Malaysia.
Great learning PCI techniques such as dual lumen catheter parallel wiring, CTO wires such as Gaia family, UltimateBro 3, estimating stent length with IVUS.
Example of CTO angioplasty with retrograde technique
The yearly interventional cardiology event ENCORE Seoul was a very successful event in Korea!
Due to unforeseen circumstances, I could not attend as physical delegate and have to present my case as online delegate.
Was happy to able to share my case from IJN to the world of cardiology in Korea!
Hope for to come in future & I’m looking forward to TCTAP 2023!
Boston Scientific organized a bifurcation workshop for cardiology fellows around Malaysia.
It was held at EQ Hotel Kuala Lumpur on 15 April 2023, chaired by Datuk Dr Kumara (IJN) with Dr Choo Gim Hooi (CVSKL), Dr Jayakhantan (IJN) & Dr Dhamaraj (Hospital Alor Setar).
It was a very well organized workshop to learn how to deal with bifurcation lesion, from provisional stenting to DK Crush technique.
Learnt a lot from this wonderful workshop, definitely hope for more in future!
10 August 2022 was the day I went live on IJN Facebook page to talk about stress test or EST or treadmill test.
The above video was from IJN Official Facebook page.
In this video, I talked about what is EST, who should do it, how to do it, any alternative and the goods/bads about EST.
It was a great Friday night out with a group of doctors from MediPulse and meeting new friends from AstraZeneca.
Topic was on how to protect cardiorenal beyong HbA1c in a diabetic patient and followed by the importance on treating early high cholesterol patient.
Forxiga is a brand name for the medication dapagliflozin, which belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Forxiga is used to treat type 2 diabetes by lowering blood sugar levels. It works by blocking the SGLT2 protein in the kidneys, which reduces the reabsorption of glucose from the kidneys and leads to increased excretion of glucose in the urine.
Forxiga is usually taken orally as a tablet once a day. It may be prescribed alone or in combination with other diabetes medications, such as metformin or insulin. Forxiga is not recommended for people with type 1 diabetes or diabetic ketoacidosis.
Great interactions with the friendly doctors from MediPulse & managers from AZ.
Crestor is a brand name for the medication rosuvastatin, which belongs to a class of drugs called statins. It is used to lower high levels of cholesterol and triglycerides in the blood, which can reduce the risk of heart attack, stroke, and other cardiovascular diseases.
Crestor works by blocking an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the liver. By reducing the production of cholesterol, Crestor helps to decrease the amount of LDL (“bad”) cholesterol in the blood, while increasing the levels of HDL (“good”) cholesterol.
Crestor is usually taken orally as a tablet once a day, with or without food.
Great place, great friends, great food!
